Jump to content

News Forum - Low demand, supply surplus leads J&J to suspend sales forecast of Covid vaccine


Thaiger
 Share

Recommended Posts

Pharmaceutical giant Johnson & Johnson says it’s currently unable to provide a sales forecast for its Covid-19 vaccine. According to the firm, vaccine hesitancy in low-income countries, coupled with existing low demand in wealthier nations, has led to a surplus of stock. J&J had previously forecast sales of up to US$3.5 billion for this year, according to a Reuters report. Demand for the J&J single-dose vaccine has been affected by reports of rare but potentially fatal blood clots linked to the jab, along with manufacturing hiccups and concerns about the vaccine’s efficacy when compared to others. The J&J vaccine makes […]

The story Low demand, supply surplus leads J&J to suspend sales forecast of Covid vaccine as seen on Thaiger News.

Read the full story

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Unfortunately, your content contains terms that we do not allow. Please edit your content to remove the highlighted words below.
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

 Share

×
×
  • Create New...

Important Information

By posting on Thaiger Talk you agree to the Terms of Use